^
    5years
    A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington's Disease (clinicaltrials.gov)
    P3; N=660 --> 909
    Enrollment change • Clinical
    |
    R 723
    almost6years
    A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington's Disease (clinicaltrials.gov)
    P3; Not yet recruiting --> Recruiting
    Enrollment open • Clinical
    |
    R 723
    6years
    A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington's Disease (clinicaltrials.gov)
    P3; N=660; Not yet recruiting; Sponsor:Hoffmann-La Roche
    New P3 trial • Clinical
    |
    R 723